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Abstract
Background and Aims: There are several known methods for cancer treatments which are one
method of treatnoent is immunotherapy. Live attenuated recombinant vector vaccine is one of the
methods of immunotherapy. This vectors can be used for a delivery system for tumor-associated
antigen in tumor immunotherapy- Prostate-specific antigen (PSA) increase in patients with
prostate cancer and could be a target for ffeatment of prostate cancer. In this article, we used the
attenuated line of Leishmania major (H-line) that previously attenuated with gentamicin by
Hamid Daneshvar. He demonstrated that attenuated strain of Leishmania major is safe- The aim
of this study was to cloning PSA gene into attenuated Leishmania major(H-line) and evaluate of
the immunogenicity of recombinant l*ishmania major in BALB/c mouse.
Material and Methods: In the present study, we cloned human PSA gene into attenuated
Leishmania major and we detected expression of PSA gene in recombinant Leishmania major by
westerc blotting- To investigate the exogenous protein-specific immunity stimulated by the
transgenic parasites, twenty Inbred BALBIc mouse were randomly diskibuted into 4 groups.
The fust groups of mouses inoculated Leishmania major Wild type. The second group inoculated
affenuated Leishmania major. The third group inoculated recombinant Leishmania major- The
last group of mouses inoculated PBS as the control- 2 months later, all mouses were euthanized.
Splenocfies were isolated, and single cell suspensions were prepared. Recombinant Leishmania
major, and Leishmania major WT and attenuated Leislunania major were added separately as in
vitro stimulus. A cell stimulation cocktail containing PMA and ionomycin was used as a positive
stimulus. Lymphocytes were harvested 24h after stimulatisn and total RNA was exfraeted. Tota1
cDNA was synthesized. The primer pairs used for analysis of IFN-gamma specific genes were
designed through NCBI Primer Designing Tool.Quantitative real-time PCR was performed.
Relative gene expression was calculated.
Results: The PSA gene cloned into Leishmania major HJine successfully for the first time and
we could detected expression of PSA gene in leishmania major H-line. We found that the
transcriptional level of IFN-y of the splenocytes of recombinant Leishmania major was highest
among the group, and there was the significant difference among the immunized group after in
vitro stimulation.
Conclusions :These findings represent that Leishmania major H-line could be used as a new
vector vaccine for expression of TAAS and other proteins that cannot express to other delivery
systems. The use of live attenuated Leishmania major preparations as candidate vaccines is very
W
promising because they most closely mimic the natural course of infection and may, therefore,
elicit similar immune responses.
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